Jackson Brandon Spencer
Department of Surgery, Kalafong Provincial Tertiary Hospital, University of Pretoria, Pretoria, South Africa.
Medicine (Baltimore). 2018 Dec;97(50):e13634. doi: 10.1097/MD.0000000000013634.
The work-up of a thyroid nodule to diagnose malignancy is not always straightforward. There are various international thyroid societies each with their own guidelines on the approach to a thyroid nodule. The aim is therefore to determine whether a clinically suspicious thyroid nodule should be subjected to surgery.
A review of various international thyroid society guidelines on their approach to a suspicious thyroid nodule.
Sixty-two relevant articles were identified of which 4 current international thyroid guidelines, consisting of 6 different international societies, were reviewed. The commonalities of each of the thyroid society guidelines are imaging, with ultrasound, and cytopathology as the main diagnostic investigations. The description and the size of the nodule are the 2 most important factors on ultrasound; however, the guidelines vary in their recommendations whether to biopsy a suspicious thyroid nodule. An indeterminate group exists whereby thyroid nodules cannot be confirmed as malignant even with fine needle aspiration cytology (FNA). Although further investigations (Technetium-99m -sestamethoxyisobutylisonitryl scan, 18F-fluorodeoxyglucose positron emission tomography/computed tomography scan, and molecular testing) may assist in the diagnosis, there are limitations. There are differences in the guidelines whether suspicious nodules should be subjected to surgery.
Ultrasound and cytopathology are the 2 most appropriate investigations to diagnose whether a suspicious thyroid nodule is benign or malignant. The clinician needs to be aware of the differences between the guidelines from the various international thyroid societies, specifically concerning the indeterminate group of patients where a definitive diagnosis cannot be made. Management decisions should be discussed with a thyroid multidisciplinary team for a consensus decision whether or not to subject a patient with a suspicious thyroid nodule to surgery.
对甲状腺结节进行评估以诊断恶性病变并非总是简单直接的。有多个国际甲状腺协会,每个协会对于甲状腺结节的处理都有自己的指南。因此,目的是确定临床上可疑的甲状腺结节是否应接受手术。
回顾各国际甲状腺协会关于可疑甲状腺结节处理方法的指南。
共识别出62篇相关文章,其中对由6个不同国际协会制定的4项现行国际甲状腺指南进行了回顾。各甲状腺协会指南的共同点是将超声成像和细胞病理学作为主要诊断检查手段。结节的描述和大小是超声检查中两个最重要的因素;然而,对于是否对可疑甲状腺结节进行活检,各指南的建议有所不同。存在一个不确定组,即即使通过细针穿刺细胞学检查(FNA)也无法确诊为恶性的甲状腺结节。尽管进一步检查(锝-99m-甲氧基异丁基异腈扫描、18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描以及分子检测)可能有助于诊断,但存在局限性。对于可疑结节是否应接受手术,各指南存在差异。
超声和细胞病理学是诊断可疑甲状腺结节是良性还是恶性的两种最合适的检查方法。临床医生需要了解各国际甲状腺协会指南之间的差异,特别是关于无法做出明确诊断的不确定组患者。应与甲状腺多学科团队讨论管理决策,以就是否对可疑甲状腺结节患者进行手术达成共识。